{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:21:12Z","timestamp":1760782872972},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1997,8]]},"DOI":"10.1007\/bf02447931","type":"journal-article","created":{"date-parts":[[2006,7,30]],"date-time":"2006-07-30T21:59:21Z","timestamp":1154296761000},"page":"620-622","source":"Crossref","is-referenced-by-count":5,"title":["Septicemia due to susceptibleEnterococcus faecalis despite prophylaxis with trimethoprim-sulfamethoxazole"],"prefix":"10.1007","volume":"16","author":[{"given":"H. -A.","family":"Elsner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Laufs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02447931_CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/CMR.3.1.46","volume":"3","author":"BE Murray","year":"1990","unstructured":"Murray BE: The life and times of the enterococcus. Clinical Microbiology Reviews 1990, 3: 46\u201365.","journal-title":"Clinical Microbiology Reviews"},{"key":"BF02447931_CR2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/clinids\/19.2.231","volume":"19","author":"ME Rupp","year":"1994","unstructured":"Rupp ME, Archer GL: Coagulase-negative staphylococci: pathogens associated with medical progress. Clinical Infectious Diseases 1994, 19: 231\u2013245.","journal-title":"Clinical Infectious Diseases"},{"key":"BF02447931_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/AAC.27.1.71","volume":"27","author":"SR Crider","year":"1985","unstructured":"Crider SR, Colby SD: Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrobial Agents and Chemotherapy 1985, 27: 71\u201375.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02447931_CR4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.28.3.446","volume":"28","author":"MJ Zervos","year":"1985","unstructured":"Zervos MJ, Schaberg DR: Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid. Antimicrobial Agents and Chemotherapy 1985, 28: 446\u2013448.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02447931_CR5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/am.22.5.812-817.1971","volume":"22","author":"AE Koch","year":"1971","unstructured":"Koch AE, Burchall JJ: Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. Applied Microbiology 1971, 22: 812\u2013817.","journal-title":"Applied Microbiology"},{"key":"BF02447931_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/22.1.35","volume":"22","author":"JMT Hamilton-Miller","year":"1988","unstructured":"Hamilton-Miller JMT: Reversal of activity of trimethoprim against gram-positive cocci by thymidine, thymine and \u2018folates\u2019. Journal of Antimicrobial Chemotherapy 1988, 22: 35\u201339.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02447931_CR7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/AAC.31.5.808","volume":"31","author":"A Najjar","year":"1987","unstructured":"Najjar A, Murray BE: Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci. Antimicrobial Agents and Chemotherapy 1987, 31: 808\u2013810.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02447931_CR8","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1128\/AAC.34.9.1792","volume":"34","author":"ML Grayson","year":"1990","unstructured":"Grayson ML, Thauvin-Eliopoulos C, Eliopoulos GM, Yao JDC, DeAngelis DV, Walton L, Woolley JL, Moellering RC Jr: Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrobial Agents and Chemotherapy 1990, 34: 1792\u20131794.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02447931_CR9","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/AAC.34.9.1800","volume":"34","author":"CE Chenoweth","year":"1990","unstructured":"Chenoweth CE, Robinson KA, Schaberg DR: Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrobial Agents and Chemotherapy 1990, 34: 1800\u20131802.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02447931_CR10","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1001\/jama.252.19.2748","volume":"252","author":"GL Goodhart","year":"1984","unstructured":"Goodhart GL: In vivov in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. Journal of the American Medical Association 1984, 252: 2748\u20132749.","journal-title":"Journal of the American Medical Association"},{"key":"BF02447931_CR11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/AAC.19.1.82","volume":"19","author":"JN Bruun","year":"1981","unstructured":"Bruun JN, \u00d8stby N, Bredesen JE, Kierulf R, Lunde PKM: Sulfonamide and trimethoprim concentrations in human serum and skin blister fluid. Antimicrobial Agents and Chemotherapy 1981, 19: 82\u201385.","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["European Journal of Clinical Microbiology and Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02447931.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02447931\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02447931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02447931.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T23:17:24Z","timestamp":1652570244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02447931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["BF02447931"],"URL":"https:\/\/doi.org\/10.1007\/bf02447931","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}